Cooper Shares Outstanding 2012-2025 | COO
- Cooper shares outstanding for the quarter ending July 31, 2025 were 200M, a 0.3% decline year-over-year.
- Cooper 2024 shares outstanding were 0.2B, a 0.55% increase from 2023.
- Cooper 2023 shares outstanding were 0.199B, a 0.25% increase from 2022.
- Cooper 2022 shares outstanding were 0.199B, a 0.2% decline from 2021.
|
Cooper Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 200 |
| 2023 | 199 |
| 2022 | 199 |
| 2021 | 199 |
| 2020 | 198 |
| 2019 | 200 |
| 2018 | 199 |
| 2017 | 198 |
| 2016 | 196 |
| 2015 | 197 |
| 2014 | 196 |
| 2013 | 199 |
| 2012 | 197 |
| 2011 | 193 |
|
Cooper Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-07-31 | 200 |
| 2025-04-30 | 201 |
| 2025-01-31 | 201 |
| 2024-10-31 | 200 |
| 2024-07-31 | 201 |
| 2024-04-30 | 201 |
| 2024-01-31 | 200 |
| 2023-10-31 | 199 |
| 2023-07-31 | 200 |
| 2023-04-30 | 199 |
| 2023-01-31 | 199 |
| 2022-10-31 | 199 |
| 2022-07-31 | 198 |
| 2022-04-30 | 199 |
| 2022-01-31 | 200 |
| 2021-10-31 | 199 |
| 2021-07-31 | 199 |
| 2021-04-30 | 199 |
| 2021-01-31 | 199 |
| 2020-10-31 | 198 |
| 2020-07-31 | 198 |
| 2020-04-30 | 198 |
| 2020-01-31 | 199 |
| 2019-10-31 | 200 |
| 2019-07-31 | 200 |
| 2019-04-30 | 200 |
| 2019-01-31 | 200 |
| 2018-10-31 | 199 |
| 2018-07-31 | 199 |
| 2018-04-30 | 198 |
| 2018-01-31 | 196 |
| 2017-10-31 | 198 |
| 2017-07-31 | 198 |
| 2017-04-30 | 198 |
| 2017-01-31 | 198 |
| 2016-10-31 | 196 |
| 2016-07-31 | 196 |
| 2016-04-30 | 196 |
| 2016-01-31 | 195 |
| 2015-10-31 | 197 |
| 2015-07-31 | 197 |
| 2015-04-30 | 197 |
| 2015-01-31 | 196 |
| 2014-10-31 | 196 |
| 2014-07-31 | 196 |
| 2014-04-30 | 195 |
| 2014-01-31 | 196 |
| 2013-10-31 | 199 |
| 2013-07-31 | 199 |
| 2013-04-30 | 198 |
| 2013-01-31 | 199 |
| 2012-10-31 | 197 |
| 2012-07-31 | 197 |
| 2012-04-30 | 196 |
| 2012-01-31 | 195 |
| 2011-10-31 | 193 |
| 2011-07-31 | 196 |
| 2011-04-30 | 193 |
| 2011-01-31 | 190 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.937B | $3.895B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.158B | 23.49 |
| Becton Dickinson (BDX) | United States | $50.974B | 12.33 |
| Cardinal Health (CAH) | United States | $48.391B | 22.86 |
| West Pharmaceutical Services (WST) | United States | $19.500B | 38.34 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.310B | 0.00 |
| Align Technology (ALGN) | United States | $9.675B | 18.27 |
| Henry Schein (HSIC) | United States | $8.464B | 14.92 |
| Merit Medical Systems (MMSI) | United States | $5.191B | 25.52 |
| DENTSPLY SIRONA (XRAY) | United States | $2.230B | 7.08 |
| CONMED (CNMD) | United States | $1.361B | 9.73 |
| STAAR Surgical (STAA) | United States | $1.321B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.101B | 12.04 |
| Lifevantage (LFVN) | United States | $0.094B | 8.92 |